Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery

医学 爱丁堡产后忧郁量表 围手术期 产后抑郁症 萧条(经济学) 麻醉 不利影响 产科 安慰剂 随机对照试验 氯胺酮 怀孕 外科 内科学 焦虑 抑郁症状 精神科 病理 替代医学 遗传学 经济 生物 宏观经济学
作者
Yu Chen,Yu Guo,Han Wu,Yi-jie Tang,Suren R. Sooranna,Li Zhang,Ting Chen,Xiyuan Xie,Liangcheng Qiu,Xiaodan Wu
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (3): e240953-e240953 被引量:4
标识
DOI:10.1001/jamanetworkopen.2024.0953
摘要

Importance Postpartum depression (PPD) is one of the most common mental health conditions during the perinatal and postpartum periods, which can have adverse effects on both mother and infant. Objective To investigate the efficacy of perioperative adjunctive esketamine administration after cesarean deliveries in the prevention of PPD. Design, Setting, and Participants A single-center, double-blind, placebo-controlled, randomized clinical trial was conducted from January 1, 2022, to January 1, 2023, at Fujian Provincial Hospital among 298 women aged 18 to 40 years, with an American Society of Anesthesiologists grade I to III classification and singleton full-term pregnancies who were scheduled for elective cesarean deliveries. Primary analyses were performed on a modified intention-to-treat basis. Interventions Patients were randomly assigned to the esketamine (n = 148) and control (n = 150) groups. Those in the esketamine group received a single intravenous injection of 0.25 mg/kg of esketamine immediately after fetal delivery, followed by 50 mg of esketamine as an adjuvant in patient-controlled intravenous analgesia for 48 hours after surgery. Saline was given to the control group of patients. Main Outcomes and Measures The primary outcome was assessments of PPD symptoms by using the Edinburgh Postnatal Depression Scale (EPDS) at postpartum day 7. Positive screening for PPD was defined as a score of 10 or more points on the EPDS. In addition, the EPDS was analyzed as a continuous variable to evaluate depressive symptoms. Secondary outcomes included the Numeric Rating Scale (NRS) of postoperative pain, along with safety evaluations including adverse events and clinical assessments at postpartum days 14, 28, and 42. Results A total of 298 pregnant women were included, with 150 in the control group (median age, 31.0 years [IQR, 29.0-34.0 years]) and 148 in the esketamine group (median age, 31.0 years [IQR, 28.0-34.0 years]). The prevalence of depression symptoms was significantly lower among patients given esketamine compared with controls (23.0% [34 of 148] vs 35.3% [53 of 150]; odds ratio, 0.55; 95% CI, 0.33-0.91; P = .02) on postpartum day 7. In addition, the esketamine group also showed a significantly lower change in EPDS scores (difference of least-squares means [SE], −1.17 [0.44]; 95% CI, −2.04 to −0.31; effect size, 0.74; P = .008). However, there were no differences between the groups in the incidence of positive screening results for PPD or in changes from the baseline EPDS scores at postpartum days 14, 28, and 42. There were no differences in NRS scores at rest and on movement except on movement at 72 hours postoperatively, when scores were significantly lower in the esketamine group (median, 3.0 [IQR, 2.0-3.0] vs 3.0 [IQR, 3.0-3.5]; median difference, 0 [95% CI, 0-0]; P = .03). Conclusions and Relevance These results suggest that intravenous administration of esketamine during the perioperative period of elective cesarean delivery can improve depression symptoms during the early postpartum period. However, this antidepression effect may not be universally applicable to patients with low EPDS scores. Trial Registration Chinese Clinical Trial Registry Identifier: ChiCTR2100054199
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
kk完成签到,获得积分10
2秒前
wancheng_发布了新的文献求助20
2秒前
7秒前
9秒前
10秒前
10秒前
11秒前
12秒前
冷静乌发布了新的文献求助10
13秒前
苗条的听寒完成签到,获得积分10
15秒前
15秒前
vanshaw.vs发布了新的文献求助10
16秒前
活力安南完成签到,获得积分10
16秒前
wancheng_发布了新的文献求助10
16秒前
脑洞疼应助renhu采纳,获得10
17秒前
研友_Z72Ydn发布了新的文献求助10
18秒前
CipherSage应助水星采纳,获得10
19秒前
19秒前
柒柒发布了新的文献求助30
20秒前
SciEngineerX完成签到,获得积分10
21秒前
XSB完成签到,获得积分10
21秒前
紫愿完成签到 ,获得积分10
23秒前
先森完成签到,获得积分10
24秒前
英姑应助vanshaw.vs采纳,获得10
24秒前
追寻的雁菡完成签到,获得积分10
25秒前
可爱的函函应助雨曦采纳,获得10
25秒前
wancheng_完成签到,获得积分10
25秒前
LIUJIE发布了新的文献求助10
28秒前
29秒前
32秒前
紧张的刺猬完成签到,获得积分10
33秒前
雨曦完成签到,获得积分20
35秒前
renhu发布了新的文献求助10
36秒前
雨曦发布了新的文献求助10
38秒前
科研通AI2S应助冷静乌采纳,获得10
40秒前
ss发布了新的文献求助30
40秒前
kajimi完成签到,获得积分10
42秒前
zx发布了新的文献求助20
43秒前
叮叮完成签到,获得积分10
45秒前
高分求助中
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
Blattodea, Mantodea, Isoptera, Grylloblattodea, Phasmatodea, Dermaptera and Embioptera, Volume 3, Part 2 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3165510
求助须知:如何正确求助?哪些是违规求助? 2816611
关于积分的说明 7913235
捐赠科研通 2476117
什么是DOI,文献DOI怎么找? 1318699
科研通“疑难数据库(出版商)”最低求助积分说明 632179
版权声明 602388